...
首页> 外文期刊>Journal of Breast Cancer >Meeting Highlights: The Second Consensus Conference for Breast Cancer Treatment in Korea
【24h】

Meeting Highlights: The Second Consensus Conference for Breast Cancer Treatment in Korea

机译:会议重点:在韩国举行的第二届乳腺癌治疗共识会议

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The Korean clinical practice guideline recently developed by the Korean Breast Cancer Society to address the national clinical situation is currently under revision ahead of a seventh recommendation. A second consensus conference was held to further develop this guideline by soliciting opinions regarding important issues related to surgery, radiotherapy, and medical oncology. Several issues were discussed, and the discussion progressed to pros and cons in the context of cases in various clinical situations. The panels discussed and voted on issues regarding surgical treatment for non-axillary regional lymph nodes, regional nodal irradiation of pN1 disease, and ovarian functional suppression (OFS) as an adjuvant treatment in premenopausal patients with hormone receptor-positive breast cancer. Regarding the surgical treatment of non-axillary regional lymph node, most panelists agreed with the recommendation of preoperative chemotherapy and postoperative radiotherapy for patients with biopsy-diagnosed metastases, whereas surgery or radiotherapy of non-axillary regional lymph nodes was suggested for clinical partial responders. Discussions on radiotherapy addressed the need for adjuvant radiotherapy and radiation field of regional lymph node in the context of various N1 breast cancer cases. The participants reached a consensus to recommend that N1 patients should receive regional nodal irradiation for a large tumor burden (e.g., three positive nodes, perinodal extension, or large primary tumor). Finally, the panels favored OFS in addition to endocrine therapy for premenopausal women with high risk factors such as a large tumor size, involvement of more than three nodes, and a high histologic grade.
机译:韩国乳腺癌协会最近针对国家临床情况制定的韩国临床实践指南,目前正在修订,而之前是第七项建议。举行了第二次共识会议,以通过征求有关外科,放射疗法和医学肿瘤学的重要问题的意见来进一步制定本指南。讨论了几个问题,并且讨论在各种临床情况下的情况下都有利有弊。小组讨论并投票表决了绝经前激素受体阳性乳腺癌患者的非腋窝区域淋巴结手术治疗,pN1疾病的区域淋巴结照射和卵巢功能抑制(OFS)作为辅助治疗的问题。关于非腋窝区域淋巴结的外科手术治疗,大多数小组成员都同意对活检诊断为转移灶的患者进行术前化疗和术后放疗的建议,而临床非部分反应者则建议手术或非腋窝区域淋巴结放疗。关于放疗的讨论解决了在各种N1乳腺癌病例中需要辅助放疗和局部淋巴结放疗领域的需求。参与者达成共识,建议N1患者应为肿瘤负荷大(例如三个阳性淋巴结,淋巴结扩展或原发性大肿瘤)接受局部淋巴结照射。最后,对于具有高风险因素(例如肿瘤大,涉及三个以上淋巴结且组织学等级高)的绝经前妇女,专家组更青睐OFS和内分泌治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号